Current Activities

Clinical Trials 

  1. Comparison of the efficacy of sequential therapy for 10-day and 14-day versus triple therapy for 14-day in the first line treatment for Helicobacter pylori infection and impact of antibiotic resistance–a multicenter randomized trial
  2. The efficacy of genotypic resistance guided sequential therapy in the third line treatment for Helicobacter pylori infection- A multicenter clinical trial
  3. Therapeutic Response to Lansoprazole among Different Subgroups of Functional Dyspepsia: a multicenter, randomized, double-blind, placebo-controlled trial
  4. Impact of genetic polymorphism of proinflammatory cytokines, Helicobacter pylori infection, and atrophic gastritis on the treatment response to lansoprazole in gastroesophageal reflux diseases
  5. Screening and eradication of H. pylori in first and second degree  relatives of gastric cancer patients
  6. Application of iFOBT and H. pylori stool antigen test in the screening of gastric cancer and colorectal cancer 
  7. Comparison of oral and intravenous proton pump inhibitors in the treatment of non-variceal upper gastrointestinal bleeding after endoscopic hemostasis 
 
Clinical and Translational Studies 
  1. Using IGF-2 and IGFBP2 as diagnostic and prognostic biomarkers of gastric cancer  
  2. Genetic polymorphisms in gastric acid secretion related genes and gastroduodenal diseases
  3. Genetic polymorphisms in PSCA and MUC1genes and gastric cancer and gastric MALToma 
 
Epidemiological Studies 
  1. Multi-centre Cross-sectional Endoscopic Screening Study for gastric cancer and its precursor lesions in Asia
  2. Screening of Helicobacter pylori and its associated diseases and analysis of antibiotic resistance—a multicenter study by H. pylori Study Consortium in Taiwan
  3. The accuracy of immune based fecal occult blood test in the detection of gastric cancer and colorectal cancer